Abstract:Feline calicivirus (FCV) causes upper respiratory tract diseases and even death in cats, thereby acting as a great threat to feline animals. Currently, FCV prevention is mainly achieved through vaccination, but the effectiveness of vaccination is limited. In this study, 105 FCV strain VP1 sequences with clear backgrounds were downloaded from the NCBI and subjected to a maximum likelihood method for systematic evolutionary analysis. Based on the genetic analysis results, FCV-positive sera were prepared using SPF mice and Chinese field cats as target animals, followed by a cross-neutralization assay conducted on the different genotype strains and in vivo challenge tests were carried out to further verify with the strain with best cross-protection effect. The results revealed that FCV was mainly divided into two genotypes: GI and GII. The GI genotype strains are prevalent worldwide, but all GII genotype strains were isolated from Asia, indicating a clear geographical feature. This may form resistance to FCV prevention in Asia. The in vitro neutralization assay conducted using murine serum demonstrated that the cross-protection effect varied among strains. A strain with broad-spectrum neutralization properties, DL39, was screened. This strain could produce neutralizing titers (10 × 2 3.08 –10 × 2 0.25 ) against all strains used in this study. The antibody titers against the GI strains were 10 × 2 3.08 –10 × 2 0.5 and those against the GII strains were 10 × 2 0.75 –10 × 2 0.25 . Preliminary evidence suggested that the antibody titer of the DL39 strain against GI was higher than that against GII. Subsequent cross-neutralization assays with cat serum prepared with the DL39 strain and each strain simultaneously yielded results similar to those described above. In vivo challenge tests revealed that the DL39 strain-immunized cats outperformed the positive controls in all measures. The results of several trials demonstrated that strain DL39 can potentially be used as a vaccine strain. The study attempted to combine the genetic diversity and phylogenetic analysis of FCV with the discovery of potential vaccines, which is crucial for developing highly effective FCV vaccines.

Isolation and Identification of Feline Parvovirus

Isolation and identification of canine parvovirus strain HZ0761

Isolation and Identification of Feline Herpesvirus Type 1

Isolation and Characterization of Feline Panleukopenia Virus from a Diarrheic Monkey.

Isolation and Phylogenetic Analysis of Feline Calicivirus Strains from Various Region of China

Isolation and Identification of Porcine Parvovirus

Isolation and Genomic Characteristics of a Novel Pathogenicity Type I Feline Coronavirus in Mainland China

Isolation and Identification of a Feline Herpesvirus-1 Strain

Isolation and Biological Characterization of Canine Parvovirus Isolates

Isolation and phylogenetic analysis of strains of feline calicivirus in Beijing, China

EIsolation, Genomic Characterization and Pathogenicity of a Feline Calicivirus Strain Ch-Jl4 from Chinese Stray Cats

Development of a reverse genetics system for a feline panleukopenia virus

Molecular Characterization of Feline Parvovirus from Domestic Cats in Henan Province, China from 2020 to 2022

Identification, Genetic Characterization, and Pathogenicity of Three Feline Herpesvirus Type 1 Isolates from Domestic Cats in China

Study of in Situ Polymerase Chain Reaction Assay for Detection of Canine Parvovirus(CPV) in Feline Kidney F81 Cells

Identification and Genome Characterization of Novel Feline Parvovirus Strains Isolated in Shanghai, China

Novel parvovirus in cats, China

Isolation and molecular characteristics of a recombinant feline calicivirus from Qingdao, China

Isolation and Identification of Canine Parvovirus Sichuan Strains

Isolation,identification and sequence analysis of complete genome of feline panleukopenia virus in Guangzhou area

Classification of genotypes based on the VP1 gene of feline calicivirus and study of cross-protection between different genotypes